Aspirin and intracerebral hemorrhage: Where are we now?

Réza Behrouz; Chad M. Miller

doi:10.1212/CPJ.0000000000000089

Aspirin and intracerebral hemorrhage: Where are we now?

Réza Behrouz, Chad M. Miller

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.

Original language	English (US)
Pages (from-to)	11-16
Number of pages	6
Journal	Neurology: Clinical Practice
Volume	5
Issue number	1
DOIs	https://doi.org/10.1212/CPJ.0000000000000089
State	Published - Feb 20 2015
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/CPJ.0000000000000089

Cite this

@article{e47f788b31c64eb4900e910f6eb22f41,

title = "Aspirin and intracerebral hemorrhage: Where are we now?",

abstract = "For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.",

author = "R{\'e}za Behrouz and Miller, {Chad M.}",

year = "2015",

month = feb,

day = "20",

doi = "10.1212/CPJ.0000000000000089",

language = "English (US)",

volume = "5",

pages = "11--16",

journal = "Neurology: Clinical Practice",

issn = "2163-0402",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Aspirin and intracerebral hemorrhage

T2 - Where are we now?

AU - Behrouz, Réza

AU - Miller, Chad M.

PY - 2015/2/20

Y1 - 2015/2/20

N2 - For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.

AB - For the past 3 decades, aspirin has been widely used for prevention of ischemic stroke and myocardial infarction. Although the evidence supporting the effectiveness of aspirin in prevention of vascular events is clear, data regarding the risk of acute and recurrent intracerebral hemorrhage related to the use of this medication have been conflicting. We review past and contemporary data on aspirin use in relation to intracerebral hemorrhage.

UR - http://www.scopus.com/inward/record.url?scp=84923233825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923233825&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0000000000000089

DO - 10.1212/CPJ.0000000000000089

M3 - Article

AN - SCOPUS:84923233825

VL - 5

SP - 11

EP - 16

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 1

ER -

Aspirin and intracerebral hemorrhage: Where are we now?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this